Stock Market

Stoke Therapeutics Stock Up 340% as Chair Sells $174K in Shares

By Bullbit Editorial · March 28, 2026

WhatStoke Therapeutics stock surged **340%** in the past year, with a recent sale by the chair.
WhyThe chair sold **$174,000** in shares, which may be seen as a signal to investors to take profits.
SignalThe insider sale could indicate a shift in sentiment among company leaders.
TargetInvestors may be eyeing a potential pullback or consolidation in the stock price.
RiskThe sale may also signal a risk of further price volatility in the coming weeks.